×

close

Monoclonal antibodies

International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01

sections/codes in this section ()

• Cemiplimab  (XM9Z80)
• Elotuzumab  (XM10Z6)
• Daratumumab  (XM4ES5)
• Mogamulizumab  (XM3JP4)
• Inotuzumab ozogamicin  (XM8648)
• Olaratumab  (XM3DU2)
• Durvalumab  (XM7NY5)
• Ermekumab  (XM6PT2)
• Avelumab  (XM2065)
• Atezolizumab  (XM8SU2)
• Necitumumab  (XM5WX4)
• Alemtuzumab  (XM5WX2)
• Erenumab  (XM8LF5)
• Galcanezumab  (XM4XM4)
• Fremanezumab  (XM47L7)
• Ubrogepant  (XM46X2)
• Eptinezumab  (XM1D23)
• Rimegepant  (XM8C95)
• Atogepant  (XM4W34)
• Brentuximab vedotin  (XM5VT7)
• Rituximab  (XM3AY3)
• Trastuzumab  (XM2FU8)
• Gemtuzumab ozogamicin  (XM1WL2)
• Cetuximab  (XM3VL3)
• Bevacizumab  (XM5ST9)
• Panitumumab  (XM1GA2)
• Catumaxomab  (XM9P40)
• Ofatumumab  (XM2KB4)
• Ipilimumab  (XM5JH7)
• Edrecolomab  (XM52L2)
• Pertuzumab  (XM6618)
• Trastuzumab emtansine  (XM6H29)
• Obinutuzumab  (XM6ES5)
• Dinutuximab  (XM74W8)
• Nivolumab  (XM6M26)
• Pembrolizumab  (XM8UG5)
• Blinatumomab  (XM9BU9)
• Ramucirumab  (XM6Y05)

Thank you for choosing Find-A-Code, please Sign In to remove ads.